This chapter brings together the connections between the experience of drug use, the contextualizing social environment and the operations of capital to analyse the power of hope in driving the demand for what have been called ‘neuroenabling’ drugs. Stimulant amphetamine use, prescription use of anti-ADHD drugs and the use of antidepressants are growing at alarming rates in developing countries. Here, rather than depicting such drug use as either a form of Foucauldian social control or disease mongering, hope is constructed as its central driver. Through analysis from the vitalist tradition and insights borrowed from diverse authors such as Avital Ronell and Alberto Melucci, drugs are no longer seen as prostheses to selfhood. Hope, when mobilized, radically drives drug consumption through engaging with a need to modulate with the world, to create the body as a test site.
Unable to display preview. Download preview PDF.